Background illustration for clinical trials search

Paid Clinical Trials Everett

Discover 1,443 paid clinical trials in Everett, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

for
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8,
Location: Seattle WA, Bellingham WA, Portland OR, Clackamas OR,
Sponsor: NRG Oncology

Sex: Male

Age: 18+

Code: NCT05946213

Phase 3, Recruiting

The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study

for
Relapsing Remitting Multiple Sclerosis
Location: Seattle WA, Irvine CA, Plymouth MN, Milwaukee WI,
Sponsor: SetPoint Medical Corporation

Sex: All

Age: 22 - 60

Code: NCT06796504

Recruiting

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

for
Secondary Progressive Multiple Sclerosis (SPMS)
Location: Seattle WA, Burnaby, Vancouver, Spokane WA, Calgary,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 65

Code: NCT07225504

Phase 3, Recruiting

Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery

for
Corneal Ectasia
Location: Seattle WA, Bozeman MT, Draper UT, Palo Alto CA,
Sponsor: Glaukos Corporation

Sex: All

Age: 18+

Code: NCT03319082

Recruiting

Prospective Evaluation and Comparison of Bilateral Synergy Implants and Bilateral PanOptix Implants

for
Cataract
Location: Seattle WA, Nacogdoches TX, Panama City FL, Kingston PA,
Sponsor: Alterman, Modi, & Wolter Ophthalmic Physicians & Surgeons

Sex: All

Age: 22+

Code: NCT05186298

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
New

Maridebart Cafraglutide Versus Semaglutide in Participants With Type 2 Diabetes

for
Diabetes Mellitus, Type 2
Location: Redmond WA, Vancouver, San Diego CA, Arlington VA,
Sponsor: Amgen

Sex: All

Age: 18+

Code: NCT07866066

Phase 3, Recruiting

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

for
Obesity or Overweight, Type 2 Diabetes Mellitus
Location: Redmond WA, Vancouver, Calgary, Blackfoot ID,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT07351058

Phase 3, Recruiting

Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease

for
Peripheral Arterial Disease
Location: Redmond WA, Redding CA, Clinton UT, Northridge CA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07223593

Phase 3, Recruiting

A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk

for
Atherosclerosis, Cardiovascular Diseases, Lipoprotein(a)
Location: Redmond WA, Meridian ID, Murray UT, Las Vegas NV,
Sponsor: Eli Lilly and Company

Sex: All

Age: 45 - 70+

Code: NCT07613294

Phase 3, Recruiting

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

for
Cardiovascular Disease
Location: Redmond WA, Seattle WA, Renton WA, Tacoma WA, Victoria,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07000357

Phase 3, Recruiting

A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events

for
Atherosclerosis
Location: Lynnwood WA, Santa Rosa CA, West Hills CA,
Sponsor: Genentech, Inc.

Sex: All

Age: 18+

Code: NCT07448038

Phase 2, Recruiting

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

for
Heart Failure
Location: Redmond WA, Renton WA, Abbotsford British Columbia,
Sponsor: AstraZeneca

Sex: All

Age: 40+

Code: NCT06677060

Phase 3, Recruiting

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

for
Atrial Fibrillation (AF)
Location: Redmond WA, Tacoma WA, Puyallup WA,
Sponsor: Anthos Therapeutics, Inc.

Sex: All

Age: 65+

Code: NCT05712200

Phase 3, Recruiting

A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin

for
Growth Hormone Deficiency
Location: Seattle WA, Portland OR, Boise ID, Sacramento CA,
Sponsor: Ascendis Pharma Endocrinology Division A/S

Sex: All

Age: 1 - 18

Code: NCT05775523

Recruiting

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

for
Non-alcoholic Fatty Liver Disease
Location: Seattle WA, West Jordan UT, Santa Maria CA, Van Nuys CA,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 70+

Code: NCT07221188

Phase 3, Recruiting

A Phase 3 Study of Fenfluramine Hydrochloride in Rett Syndrome

for
Rett Syndrome
Location: Seattle WA, Irving TX, Little Rock AR, Houston TX,
Sponsor: UCB BIOSCIENCES, Inc.

Sex: All

Age: 5 - 35

Code: NCT07503444

Phase 3, Recruiting

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

for
Non-alcoholic Fatty Liver Disease
Location: Seattle WA, Folsom CA, West Jordan UT, Riverdale CA,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 70+

Code: NCT07221227

Phase 3, Recruiting

Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency

for
Growth Hormone Deficiency (GHD)
Location: Seattle WA, Sacramento CA, Madera CA, Las Vegas NV,
Sponsor: Lumos Pharma

Sex: All

Age: 3 - 11

Code: NCT06948214

Phase 3, Recruiting

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis,
Location: Seattle WA, Bellevue WA, Tacoma WA, Vancouver, Calgary,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18 - 70+

Code: NCT06318169

Phase 3, Recruiting

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

for
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis,
Location: Seattle WA, Bellevue WA, Tacoma WA, Vancouver, Calgary,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18 - 70+

Code: NCT06419374

Phase 3, Recruiting